Adaptogen HPA / cortisol stress modulation

Category: signaling

Overview

"Adaptogen" is a regulatory category (Soviet Lazarev/Brekhman 1947-69) for non-specific stress-resistance modulators acting on HPA axis + monoamines + heat-shock proteins. Mechanism evidence is patchier than pharmaceutical pathways — most adaptogen claims rest on traditional use + animal pharmacology + small clinical trials with mixed outcomes. Ashwagandha (Withania somnifera) lowers cortisol in chronic-stress samples (Indian Ayurvedic). Rhodiola rosea contains salidroside + rosavins → MAO inhibition + 5-HT modulation. Panax ginseng (Korean/American) ginsenosides modulate HPA + nitric oxide. Eleuthero (Siberian "ginseng") — separate genus, similar use. Bacopa monnieri → bacosides + cerebral blood flow + AChE modulation. Holy basil (tulsi), schisandra, maca, gotu kola, astragalus all marketed in the same category. Mechanism prose herein reflects current consensus — many specific claims need full-text trial citation for kinetic parameters.

Organ Systems

Pathway Steps

  1. chronic-psychophysical-stress → hpa-axis-dysregulation — via sustained cortisol elevation + reduced negative feedback sensitivity. Chronic physical or psychological stress dysregulates the HPA axis — flattening cortisol rhythms and impairing feedback — a state linked to fatigue and metabolic/mood disturbance. This maladaptive stress response is the target adaptogens are proposed to normalize.
  2. adaptogen-extract → normalized-hpa-output — via mechanism varies — monoamine modulation + HSP induction + cortisol-curve flattening. Adaptogens (Rhodiola, ashwagandha, Eleutherococcus) are proposed stress-response modulators that nudge a dysregulated HPA axis back toward balance (a hormesis/“eustress” concept) rather than simply stimulating or sedating. Clinical evidence is mixed and mechanisms remain incompletely defined.

Known Modulators

References